Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-071476

Options or other derivatives

  • General Counsel acquired 269,067 shares (grant or award)
  • General Counsel returned 269,067 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Groen Eric General Counsel 2023-12-16 Returned to the company · Stock Option (Right to Buy) −171,500 34,300 D: show line 1 in the form
Groen Eric General Counsel 2023-12-16 Grant or award · Stock Option (Right to Buy) +171,500 171,500 D: show line 2 in the form
Groen Eric General Counsel 2023-12-16 Returned to the company · Stock Option (Right to Buy) −43,400 31,000 D: show line 3 in the form
Groen Eric General Counsel 2023-12-16 Grant or award · Stock Option (Right to Buy) +43,400 43,400 D: show line 4 in the form
Groen Eric General Counsel 2023-12-16 Returned to the company · Stock Option (Right to Buy) −54,167 75,833 D: show line 5 in the form
Groen Eric General Counsel 2023-12-16 Grant or award · Stock Option (Right to Buy) +54,167 54,167 D: show line 6 in the form
Loading xslF345X05/ownership.xml…